Accelerating Global Submissions: How Industry Leaders Are Reducing Time to Market With the Accumulus Platform
A CUSTOMER FIRESIDE CHAT
April 22nd | 10 - 11 am EDT
A process that once took years, hundreds of interactions, and millions in cost can now be executed in months with a single shared submission—unlocking substantial operational and economic value at scale.
So, what do faster global approvals look like in practice and what results are customers seeing today?
Join us for a live fireside chat with leaders from Sanofi, Roche, and Amgen as they share the real-world impact they’re achieving with the Accumulus platform. In this candid conversation, you’ll hear firsthand how teams are accelerating global submissions, reducing time to market, and operating in a connected, real-time model of collaboration between industry and regulators—for the benefit of patients worldwide.
Hear directly from peers who have:
• Achieved up to 75% efficiency gains by eliminating manual coordination across markets
• Unlocked millions through faster, more efficient submissions
In this moderated discussion, panelists will share insights from real submissions and active use, including the challenges they set out to solve, lessons learned along the way, and the unprecedented impact of Accumulus Technologies’ Accelerated Collaborative Review Model.
Featured Speakers:



Melly Lin
Regional Policy Lead, Roche
Margaret Leahey
Senior Director,
Global CMC Biologics, Sanofi
J. Paul Kirwan
Senior Manager Global Regulatory Affairs CMC, Amgen
